Evidence map›Paper›PMID 29311128›Full record

ReviewCold Spring Harbor perspectives in medicine2018

Chemoprevention in Prostate Cancer: Current Perspective and Future Directions.

J Ricardo Rivero, Ian M Thompson, Michael A Liss, Dharam Kaushik

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cold Spring Harbor perspectives in medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

J Ricardo RiveroDepartment of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229.
Ian M ThompsonDepartment of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229.
Michael A LissDepartment of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229.
Dharam KaushikDepartment of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229.
The University of Texas Health Science Center at San Antonio · US

Funding

SWOG Foreign AccrualsU10CA037429 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BLANKE, CHARLES D., MEYSKENS, FRANK L. · 1985 to 2014
$205.2M
SWOG NCORP Research BaseUG1CA189974 · NCI · THE HOPE FOUNDATION · PI CHARLES D. BLANKE, DAWN HERSHMAN · 2014 to 2026
$80.6M
NCI NIH HHS U10 CA037429NCI NIH HHS UG1 CA189974
6 · The paper itself

Abstract

Chemoprevention of prostate cancer aims to reduce the mortality as well as the public burden of overdetection, which increases anxiety, cost, and morbidity related to the disease. The role of 5-α-reductase inhibitors has been well investigated and shown to decrease the risk of prostate cancer. No current evidence exists to encourage the use of nutrients or vitamins as chemopreventive agents. The modulation of inflammation is one of the most promising targets for chemoprevention of prostate cancer.

Indexed as

5-alpha Reductase InhibitorsHumansMaleProstatic Neoplasms5-alpha Reductase Inhibitors

Identifiers

PMID29311128
PMCPMC6169981
OpenAlexW2782902061

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.